Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines : insights from a web-based physician survey
Ver / Descargar
Fecha
2020-06-10Autor(es)
Barter, Philip J.Yamashita, Shizuya
Laufs, Ulrich
Ruiz, Alvaro J.
Sy, Rody
G. Fang, Mark David
Folco, Emanuela
Libby, Peter
Matsuzawa, Yuji
Santos, Raul D.
Autor(es) Corporativo(s)
Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Epidemiología Clínica y Bioestadística
Tipo
Artículo de revista
ISSN
1476-511X
Páginas
1-9
Tipo de artículo
Artículo completo
Compartir este registro
Citación
Documentos PDF
Título en inglés
Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines : insights from a web-based physician surveyAbstract
Background: Implementing evidence-based management of dyslipidaemia is a challenge worldwide.
Objectives: To understand physician beliefs and behaviour and identify uncertainties in dyslipidaemia management
across four world regions.
Methods: Web-based survey of 1758 physicians in Japan, Germany, Colombia and the Philippines who were
selected randomly from existing databases. Key inclusion criteria were 1) for cardiologists and diabetes/
endocrinology specialists: ≥50 dyslipidaemia patients examined in the last month; 2) for specialists in neurology/
neurosurgery/stroke medicine: ≥50 dyslipidaemia patients and ≥ 20 patients with a history of ischaemic stroke
examined in the last month; and 3) for specialists in nephrology and general medicine: based at centres with ≥20
beds and ≥ 50 dyslipidaemia patients examined in the last month. The self-report survey covered dyslipidaemia
management, target low-density lipoprotein cholesterol (LDL-C) levels in different patient groups, and statin safety.
All physicians gave voluntary consent and all data were anonymised. Analysis was solely descriptive.
Results: The survey highlighted key areas of uncertainty in dyslipidaemia management in the four countries. These
related to LDL-C targets in different patient groups, the safety of low LDL-C levels, the safety of statins, especially
for effects on cognitive, renal and hepatic function and for haemorrhagic stroke risk, and lipid management
strategies in patients with chronic kidney disease, including those with concomitant hypertriglyceridaemia.
Conclusions: This survey of physicians in Japan, Germany, Colombia and the Philippines has identified key gaps in
knowledge about dyslipidaemia management. These relate to the safety of low LDL-C levels, the safety of statins,
and lipid management of chronic kidney disease. The findings from this survey highlight the need for further
education to improve the implementation of guideline recommendations for dyslipidaemia management
Keywords
Low-density lipoprotein cholesterolAtherosclerotic cardiovascular disease
Haemorrhagic stroke
Chronic kidney disease
Statins
Safety
Enlace al recurso
https://lipidworld.biomedcentral.com/articles/10.1186/s12944-020-01265-zFuente
Lipids in Health and Disease; (2020)
Estadísticas Google Analytics
Colecciones
- Artículos [682]